glp 1 bcbs Blue Cross Blue Shield Drops Coverage of GLP-1 Obesity Drugs GLP-1 for Weight Loss and

5 Although the existing level of evidence with these new medications is limited in quality, the known mechanisms of action and current case reports indicate that patients taking GLP-1 or GLP-1/GIP receptor agonists are at a higher risk for retaining complex solid gastric contents despite following American Society of Anesthesiologists (ASA) preoperative fasting guidelines

& Tuttle, K

Most symptoms are mild to moderate and improve over time as the body adjusts, though some patients may experience persistent symptoms requiring management strategies

this is not something founders can execute quickly without specialized engineering and operational support